Novarad Adds Three PACS Installs in Nebraska

American Fork, Utah, July 29, 2013 – Novarad is further expanding its installation base in Nebraska, adding three new facilities to its roster. Novarad’s distributor, Brown’s Medical Imaging facilitated contracts with the following healthcare facilities:

- Creighton Medical Associates, a clinic in Omaha

- Harlan County Health Systems, an imaging center in Alma

- West Holt Memorial Hospital in Atkinson

Nebraska is one of Novarad’s flagship states; it has multiple installations of PACS, RIS and other radiology technologies from its Diagnostic Radiology Suite in multiple locations. 

Factors that contributed to these facilities selecting NovaPACS included, local service through Brown’s Medical Imaging, a complete but affordable PACS that is consistently top KLAS rated, easy to use and comes with lifetime software and hardware upgrades as part of the contract.

About Novarad

With more than 850 installations worldwide, Novarad is the healthcare community's trusted provider of radiology technologies. Novarad's full diagnostic suite of PACS, RIS, cardiology, orthopedic and mammography systems increase radiology efficiency and deliver unmatched value. Images and reports are available anytime, anywhere via the full diagnostic viewer, iPad or any mobile device with web access. Novarad has been ISO certified since 2006 and holds FDA 510(k) certification.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.